Xu You
Impact in
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
- Reproductive Medicine top 10%
- Sperm and Testicular Function
Papers in
- Epidemiology 14
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 5
- Surgery 7
- Testicular diseases and treatments 3
- Co-authors
- Chui‐Hua Kong (4 shared papers)Raymond C. Harris (1 shared paper)Jianchun Chen (1 shared paper)Xuefang Yang (1 shared paper)Yan Li (1 shared paper)He Qian (1 shared paper)Huaizhou You (1 shared paper)Xin Chen (2 shared papers)
- Journals
- Diabetes Metabolic Syndrome and Obesity (3 papers)Infection and Drug Resistance (2 papers)BMC Infectious Diseases (2 papers)Experimental Gerontology (2 papers)Plant Cell & Environment (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xu You
39 papers receiving 573 citations
Peers
Comparison fields: 5 of 108
- Nephrology 68
- Reproductive Medicine 50
- Plant Science 162
- Biological Psychiatry 9
- Cell Biology 52
Countries citing papers authored by Xu You
This map shows the geographic impact of Xu You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu You more than expected).
Fields of papers citing papers by Xu You
This network shows the impact of papers produced by Xu You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu You. The network helps show where Xu You may publish in the future.
Co-authors
The 25 scholars most cited alongside Xu You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 84 | |
| 2 | 2014 | 55 | |
| 3 | 2018 | 54 | |
| 4 | 2023 | 47 | |
| 5 | 2019 | 43 | |
| 6 | 2021 | 40 | |
| 7 | 2018 | 34 | |
| 8 | 2020 | 33 | |
| 9 | 2020 | 25 | |
| 10 | 2019 | 21 | |
| 11 | 2021 | 21 | |
| 12 | 2022 | 20 | |
| 13 | 2021 | 16 | |
| 14 | 2020 | 10 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 7 | |
| 17 | Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy. | 2015 | 7 |
| 18 | 2022 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2023 | 4 |
About Xu You
Xu You is a scholar working on Epidemiology, Surgery, Nephrology, Hepatology and Reproductive Medicine, having authored 41 papers that have together received 574 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (5 papers), Sperm and Testicular Function (5 papers), Dialysis and Renal Disease Management (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Testicular diseases and treatments (3 papers) and Tuberculosis Research and Epidemiology (3 papers). The work is most often cited by research in Nephrology (68 citations), Reproductive Medicine (50 citations), Plant Science (162 citations), Biological Psychiatry (9 citations) and Cell Biology (52 citations). Xu You has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Chui‐Hua Kong, Raymond C. Harris, Jianchun Chen, Xuefang Yang, Yan Li, He Qian, Huaizhou You, Xin Chen, Haixia Zhao and Changcheng Zhang. Their work appears in journals such as Diabetes Metabolic Syndrome and Obesity, Infection and Drug Resistance, BMC Infectious Diseases, Experimental Gerontology and Plant Cell & Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.